Literature DB >> 33091740

Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review.

Manon Ansart1, Stéphane Epelbaum2, Giulia Bassignana3, Alexandre Bône3, Simona Bottani3, Tiziana Cattai4, Raphaël Couronné3, Johann Faouzi3, Igor Koval3, Maxime Louis3, Elina Thibeau-Sutre3, Junhao Wen3, Adam Wild3, Ninon Burgos3, Didier Dormont5, Olivier Colliot6, Stanley Durrleman7.   

Abstract

We performed a systematic review of studies focusing on the automatic prediction of the progression of mild cognitive impairment to Alzheimer's disease (AD) dementia, and a quantitative analysis of the methodological choices impacting performance. This review included 172 articles, from which 234 experiments were extracted. For each of them, we reported the used data set, the feature types, the algorithm type, performance and potential methodological issues. The impact of these characteristics on the performance was evaluated using a multivariate mixed effect linear regressions. We found that using cognitive, fluorodeoxyglucose-positron emission tomography or potentially electroencephalography and magnetoencephalography variables significantly improved predictive performance compared to not including them, whereas including other modalities, in particular T1 magnetic resonance imaging, did not show a significant effect. The good performance of cognitive assessments questions the wide use of imaging for predicting the progression to AD and advocates for exploring further fine domain-specific cognitive assessments. We also identified several methodological issues, including the absence of a test set, or its use for feature selection or parameter tuning in nearly a fourth of the papers. Other issues, found in 15% of the studies, cast doubts on the relevance of the method to clinical practice. We also highlight that short-term predictions are likely not to be better than predicting that subjects stay stable over time. These issues highlight the importance of adhering to good practices for the use of machine learning as a decision support system for the clinical practice.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Automatic prediction; Cognition; Mild cognitive impairment; Progression; Quantitative review

Mesh:

Year:  2020        PMID: 33091740     DOI: 10.1016/j.media.2020.101848

Source DB:  PubMed          Journal:  Med Image Anal        ISSN: 1361-8415            Impact factor:   8.545


  10 in total

1.  Brain Volumetric Alterations in Preclinical HIV-Associated Neurocognitive Disorder Using Automatic Brain Quantification and Segmentation Tool.

Authors:  Ruili Li; Yu Qi; Lin Shi; Wei Wang; Aidong Zhang; Yishan Luo; Wing Kit Kung; Zengxin Jiao; Guangxue Liu; Hongjun Li; Longjiang Zhang
Journal:  Front Neurosci       Date:  2021-08-11       Impact factor: 4.677

2.  Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer's disease dementia.

Authors:  Ali Ezzati; Ahmed Abdulkadir; Clifford R Jack; Paul M Thompson; Danielle J Harvey; Monica Truelove-Hill; Lasya P Sreepada; Christos Davatzikos; Richard B Lipton
Journal:  Alzheimers Dement       Date:  2021-11-10       Impact factor: 21.566

3.  An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer's disease.

Authors:  Qun Yu; Yingren Mai; Yuting Ruan; Yishan Luo; Lei Zhao; Wenli Fang; Zhiyu Cao; Yi Li; Wang Liao; Songhua Xiao; Vincent C T Mok; Lin Shi; Jun Liu
Journal:  Alzheimers Res Ther       Date:  2021-01-12       Impact factor: 6.982

4.  Detecting Cognitive Impairment Status Using Keystroke Patterns and Physical Activity Data among the Older Adults: A Machine Learning Approach.

Authors:  Mohammad Nahid Hossain; Mohammad Helal Uddin; K Thapa; Md Abdullah Al Zubaer; Md Shafiqul Islam; Jiyun Lee; JongSu Park; S-H Yang
Journal:  J Healthc Eng       Date:  2021-12-20       Impact factor: 2.682

5.  Explainable AI toward understanding the performance of the top three TADPOLE Challenge methods in the forecast of Alzheimer's disease diagnosis.

Authors:  Monica Hernandez; Ubaldo Ramon-Julvez; Francisco Ferraz
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.752

Review 6.  Machine learning for medical imaging: methodological failures and recommendations for the future.

Authors:  Gaël Varoquaux; Veronika Cheplygina
Journal:  NPJ Digit Med       Date:  2022-04-12

7.  Diagnostic Performance of Generative Adversarial Network-Based Deep Learning Methods for Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Changxing Qu; Yinxi Zou; Yingqiao Ma; Qin Chen; Jiawei Luo; Huiyong Fan; Zhiyun Jia; Qiyong Gong; Taolin Chen
Journal:  Front Aging Neurosci       Date:  2022-04-21       Impact factor: 5.750

8.  Early diagnosis of Alzheimer's disease using machine learning: a multi-diagnostic, generalizable approach.

Authors:  Hugo Alexandre Ferreira; Diana Prata; Vasco Sá Diogo
Journal:  Alzheimers Res Ther       Date:  2022-08-03       Impact factor: 8.823

9.  Higher-resolution quantification of white matter hypointensities by large-scale transfer learning from 2D images on the JPSC-AD cohort.

Authors:  Benjamin Thyreau; Yasuko Tatewaki; Liying Chen; Yuji Takano; Naoki Hirabayashi; Yoshihiko Furuta; Jun Hata; Shigeyuki Nakaji; Tetsuya Maeda; Moeko Noguchi-Shinohara; Masaru Mimura; Kenji Nakashima; Takaaki Mori; Minoru Takebayashi; Toshiharu Ninomiya; Yasuyuki Taki
Journal:  Hum Brain Mapp       Date:  2022-05-07       Impact factor: 5.399

10.  Toward a Multimodal Computer-Aided Diagnostic Tool for Alzheimer's Disease Conversion.

Authors:  Danilo Pena; Jessika Suescun; Mya Schiess; Timothy M Ellmore; Luca Giancardo
Journal:  Front Neurosci       Date:  2022-01-03       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.